Vitrolife AB (publ) Vitrolife AB (publ)

Vitrolife AB (publ)

VITR

Rank in Stocks #6578
Vitrolife AB (publ) is a medical technology company specializing in the... Vitrolife AB (publ) is a medical technology company specializing in the development, production, and global sale of products for assisted reproduction. Their comprehensive offering includes a variety of essential tools for fertility treatments, such as oocyte retrieval needles, sperm processing solutions, specialized in vitro fertilization media and oils, and micromanipulation pipettes. The company also provides general labware, incubators, cryopreservation products, and systems for preimplantation genetic testing. Furthermore, Vitrolife delivers advanced equipment, including the EmbryoScope and Primo Vision time-lapse systems, along with dedicated dishes and evaluation software for these platforms. Their technology portfolio extends to Octax laser and imaging systems, as well as environmental monitoring solutions like log and guard systems and wireless sensors. With its headquarters located in Gothenburg, Sweden, Vitrolife maintains a significant international presence, operating across Europe, the Middle East, and Africa; Asia; Japan and the Pacific; and both North and South America. Founded in 1994, the company was initially known as Scandinavian IVF Science before officially changing its name to Vitrolife AB (publ) in 1998.
Share Price
$11.88
Last synced: 2026-11-13
Market Cap
$1.59B
Change (1 day)
0.51%
Change (1 year)
-21.27%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Vitrolife AB (publ) (VITR)
Operating Margin as of November 2026 TTM: -138.03%
According to Vitrolife AB (publ)'s latest financial reports, its current operating margin (TTM) is -138.03%. At the end of 2025 the company had an operating margin of -140.55%.
Operating Margin history for Vitrolife AB (publ) from 2002 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -138.03% -1.79%
2025 -140.55% -747.70%
2024 21.70% -121.23%
2023 -102.19% -605.39%
2022 20.22% -21.93%
2021 25.90% -12.82%
2020 29.71% -9.89%
2019 32.97% -3.62%
2018 34.21% 5.00%
2017 32.58% 12.07%
2016 29.07% -7.12%
2015 31.30% 11.47%
2014 28.08% 58.11%
2013 17.76% 29.26%
2012 13.74% 19.58%
2011 11.49% 3.42%
2010 11.11% 0.36%
2009 11.07% -8.13%
2008 12.05% 8.27%
2007 11.13% -4.79%
2006 11.69% 16.55%
2005 10.03% -20.14%
2004 12.56% -71.13%
2003 43.50% -63.30%
2002 118.52% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
15.00% -100.11%
US
18.08% -100.13%
IE
21.25% -100.15%
US
21.05% -100.15%
US
25.52% -100.18%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Vitrolife AB (publ)'s operating margin

What is Vitrolife AB (publ)'s operating margin?

Vitrolife AB (publ)'s operating margin is -138.03%, as of Nov 2026.

What was Vitrolife AB (publ)'s operating margin in 2025?

In 2025, Vitrolife AB (publ)'s operating margin was -140.55%, compared with 21.70% in 2024.

How has Vitrolife AB (publ)'s operating margin changed since 2020?

From 2020 to 2025, Vitrolife AB (publ)'s operating margin was highest in 2020 (29.71%) and lowest in 2025 (-140.55%).

How does Vitrolife AB (publ)'s operating margin compare with similar companies?

Vitrolife AB (publ)'s operating margin (-138.03%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 25.52%.